Granite Point Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Hold |
0
| – | – | – | 125 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 142 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 154 |
|
|
2015
Q1 | – | Sell |
-40,000
| Closed | -$894K | – | 103 |
|
|
2014
Q4 | $894K | Sell |
40,000
-5,000
| -11% | -$112K | 0.42% | 44 |
|
|
2014
Q3 | $705K | Hold |
45,000
| – | – | 0.35% | 48 |
|
|
2014
Q2 | $668K | Sell |
45,000
-19,800
| -31% | -$294K | 0.46% | 50 |
|
|
2014
Q1 | $1.04M | Buy |
64,800
+9,800
| +18% | +$158K | 0.75% | 38 |
|
|
2013
Q4 | $514K | Buy |
+55,000
| New | +$514K | 0.09% | 81 |
|